CHKA and liver cancer: GO enrichment results revealed that CKI treatment for liver cancer primarily affects biological processes such as neurotransmitter receptor activity and G protein-coupled amine receptor activity and components like the synaptic membrane, dendrite, and chemical synaptic transmission and circulatory system processes (Figure 3A).